EUVIMEDEUVIMED entdecken
Crossref

L26/P-849 Reproductive outcomes after septoplasty for subseptate uterus in infertile patients: a large single-center retrospective study

O. Abuzeid, P. Cherouveim, S. Joseph, E. Budak, M. Fakih, M. Abuzeid

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von O. Abuzeid und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is hysteroscopic septoplasty for subseptate uterus in infertile patients associated with improved reproductive outcomes compared to women born with no Müllerian uterine anomalies? Summary answer Reproductive outcomes after hysteroscopic septoplasty for subseptate uterus in infertile patients are better than those of patients born with no Müllerian uterine anomalies. What is known already Subseptate and septate uteri can be associated with poor reproductive outcomes. The only randomized-control-trial failed to show any difference in reproductive outcomes in patients after septoplasty compared to expectant management, albeit with a small sample size (JFW Rikken et al 2021). However, hysteroscopic septoplasty is now recommended in patients presenting with unexplained recurrent pregnancy loss. In infertility patients, septoplasty is considered when patient shared decision-making is in favor of surgery, and many reproductive surgeons prefer to proceed with surgical correction. Septoplasty, in experienced hands, is considered a safe and effective procedure that might improve reproductive outcomes. Study design, size, duration This is a single-center historical cohort study of 2,757 infertile patients that were evaluated and treated in the period between 1990-2023. All patients underwent diagnostic, and if indicated, operative hysteroscopy under modified general anesthesia during the same session. The study group includes 1,423 infertility patients who underwent hysteroscopic septoplasty for subseptate uterus (Group 1), and the control group includes 1,334 Infertility patients who had no Müllerian uterine anomalies (Group 2). Participants/materials, setting, methods Infertility treatment options after hysteroscopy depended on underlying etiology. Options included diagnostic/operative laparoscopy, natural intercourse, fertility tablets, intrauterine insemination, and In-Vitro Fertilization. The best reproductive outcomes after treatment for each patient were included. Primary outcomes included clinical pregnancy, miscarriage, delivery, multiple gestation, and preterm delivery rates. The follow up period was two years. Student’s t-test and Chi-squared test were used as appropriate, and generalized estimating equations regression analysis was used to adjust for potential confounders. Main results and the role of chance There were no significant differences in maternal age, BMI, prior delivery history, AMH (when available), or other background details between the two groups. Patients in Group 1 had significantly lower Day 2/3 FSH and duration of infertility, but a significantly higher incidence of primary infertility, prior pregnancy, prior miscarriage, male infertility, anovulatory disorders, and uterine factors (other than Müllerian anomaly). Additionally, Group 1 had significantly lower incidence of tubal factors and endometriosis. Group 1 also had higher clinical pregnancy rates (60.9% vs. 33.7%, p = 0.001) and delivery rates (54.1% vs. 30.2%, p = 0.001) as compared to Group 2. There were no significant differences in miscarriage (10.4% vs. 9.4%, p = 0.552), multiple gestation (26.4% vs. 26.1%, p = 0.934), or preterm delivery rates (31.0% vs. 25.8%, p = 0.113) between Group 1 and Group 2, respectively. There was no significant difference in the percentage of patients who achieved pregnancy with IVF or non-IVF methods between the two groups. Adjusted Odds Ratio (95%CI) suggested that patients in Group 1 had significantly higher clinical pregnancy [3.09(1.66-5.75), p = 0.001], miscarriage [5.30(1.12-25.07), p = 0.035], and delivery rates [1.93(1.04-3.56), p = 0.036], but no significant differences in multiple gestation [1.29(0.44-3.82), p = 0.647] or preterm delivery rates [0.50 (0.15-1.75), p = 0.279, Group 2 as reference]. Limitations, reasons for caution The retrospective design introduces potential residual confounding. On the other hand, the impact of varying surgical techniques and treatment approaches on the results is reduced, given this is a single-center study. Wider implications of the findings In the absence of a randomized controlled trial with an adequate sample size, and in the era of patient shared decision-making, the data from our large study may be a useful addition to the current literature during counseling of infertile patients with subseptate uterus who prefer septoplasty over expectant management. Trial registration number No

Zitieren

APA

Abuzeid, O., Cherouveim, P., Joseph, S., Budak, E., Fakih, M., & Abuzeid, M. (2026). L26/P-849 Reproductive outcomes after septoplasty for subseptate uterus in infertile patients: a large single-center retrospective study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1176

Vancouver

Abuzeid O, Cherouveim P, Joseph S, Budak E, Fakih M, Abuzeid M. L26/P-849 Reproductive outcomes after septoplasty for subseptate uterus in infertile patients: a large single-center retrospective study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1176

BibTeX
@article{Abuzeid2026,
  author = {Abuzeid, O. and Cherouveim, P. and Joseph, S. and Budak, E. and Fakih, M. and Abuzeid, M.},
  title = {L26/P-849 Reproductive outcomes after septoplasty for subseptate uterus in infertile patients: a large single-center retrospective study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1176}
}
Kostenlos starten →